Clinical trial
Depakote ER in Borderline Personality Disorder
NCT00222482 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00222482 |
|---|---|
| Title | Depakote ER in Borderline Personality Disorder |
| Official title | A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | Abbott Industry Schulz, S. Charles, M.D. |
| Status | Completed |
| Study type | Interventional |
| Conditions | Borderline Personality Disorder |
| Intervention type | Drug |
| Interventions | Depakote ER |
| Enrollment | 15 |
| Start date | Mar 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 9, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: